Blaise Coleman
Found 5 people in New Jersey, Georgia, Washington and other states
-
+99
-
+98
-
+97
-
-
+95
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Sponsored by SpokeoPaid Service
Sponsored by SpokeoPaid Service
Blaise Coleman
Sponsored by PeopleLookerPaid Service
Search for contact info, city & state history, relatives, jobs, education & more
Search public records
Blaise Coleman - @blazerwheelz
139 followers
Blaise Coleman - @blaisecoleman
2 followers
Blaise Coleman - @themilkmann0007
54 followers
Blaise Coleman - @capncrunchi
19 followers
Levi Blaise Coleman - @leviblaise
Hi my name is Levi Blaise and welcome to my YouTube Channel! I really really love the Performance Arts I am an Actor who ...
309 subscribers
Blaise Coleman
Blaise Coleman
The Churches Conservation Trust
Art Koch
Temple University - Malvern, Pennsylvania, United States
Kathy Profrock
Executive Coordinator to the EVP and Chief ...
STEVE WONG
Robert Half
Education: University of Minnesota - Carlson ...
Scott Storer
David Dill
Jenna Cameron
Territory Sales Representative - Syneos Health
Frank Mullery
Sintetica
Education: Villanova University
Stephen Edwards
Gilead Sciences
Education: Santa Clara University ...
Blaise Coleman
Sponsored by PeopleLookerPaid Service
Search for Blaise Coleman's city and state history
Search address historyAfter guiding Endo through bankruptcy, CEO Blaise Coleman exits suddenly
FiercePharma - Tue, 27 Aug 2024
Endo CEO Blaise Coleman Retires
citybiz - Tue, 27 Aug 2024
Endo parts ways with CEO four months after emerging from bankruptcy
The Business Journals - Wed, 28 Aug 2024
Malvern’s Endo International Reaches Deal to Prepare to Emerge from Bankruptcy
VISTA.Today - Fri, 19 Jan 2024
Endo Names Blaise Coleman President and Chief Executive Officer
Canada NewsWire - Wed, 19 Feb 2020
Opioid maker Endo paid top executives $55.5 million in bonuses before bankruptcy
The Philadelphia Inquirer - Wed, 24 Aug 2022
Malvern’s Endo Finds New CEO, a Former Widener College Football All-American, from Within
DELCO.Today - Wed, 26 Feb 2020
Exclusive List: Top-Paid Pharma and Biotech CEOs in 2021
Business Insider - Wed, 25 May 2022
Endo replaces CEO, appoints M&A specialist to board in possible push for deals
FiercePharma - Thu, 20 Feb 2020
Executive bonuses at Malvern opioid firm Endo were ‘excessive’ and ‘secret’ before bankruptcy, state AGs say
The Philadelphia Inquirer - Fri, 23 Sep 2022
Malvern’s Endo Finds New CEO, a Former College Football All-American, from Within
VISTA.Today - Tue, 25 Feb 2020
Endo to cut 560 staffers, shutter drug plants to save cash for spring cellulite launch
FiercePharma - Thu, 05 Nov 2020
Amid overwhelming opioid litigation, Endo files for bankruptcy and inks $450M settlement
FiercePharma - Wed, 17 Aug 2022
Blaise Coleman - @rubixreaper
2 followers
Blaise Coleman - @password7777
0 followers
Gabby Blaise-Coleman - @blaisecoleman
1 follower
Blaise Coleman - @bcoleman0369
0 followers
Blaise Coleman - @blaisecoleman7
0 followers
Blaisecoleman - @blaisecoleman0006
0 followers
Blaise Coleman - President & Chief Executive Officer @ Endo Pharmaceuticals
www.crunchbase.com
Levi Blaise Coleman
www.imdb.com
Endo CEO Blaise Coleman departs after company emerges from …
Four months after emerging from bankruptcy, Endo is in transition again with the sudden departure of CEO Blaise Coleman. Tuesday, without providing a reason, the Dublin-based company revealed...
Malvern’s Endo Finds New CEO, a Former College Football All-American ...
Endo International, the Dublin-based pharmaceutical company that has its U.S. headquarters in Malvern, has found its new CEO in Blaise Coleman. He is currently the company’s executive vice president and chief financial officer, a role he has been in for the last four years, writes John George for the Philadelphia Business Journal .
ENDO ANNOUNCES CEO TRANSITION - Aug 27, 2024
Mr. Herendeen continued, "On behalf of the Board of Directors, we thank Blaise for his successful leadership of Endo over the last four years, which were integral to establishing our strong foundational footing following our restructuring, and we welcome Scott to lead the Company during this transition period.
Endo CEO Blaise Coleman Retires - citybiz
Endo, Inc. (OTCQX: NDOI), a diversified specialty pharmaceutical company transforming insights into life-enhancing therapies, today announced that the Board of Directors has initiated a search for the Company’s next Chief Executive Officer and that Blaise Coleman will depart the Company as President & CEO and from the Board of Directors ...
Opioid maker Endo paid top executives $55.5 million in bonuses …
Days before the money-losing opioid drug firm Endo International filed for bankruptcy last week, the company paid chief executive Blaise Coleman an $11.85 million bonus.
Endo CEO to depart, search process initiated - MSN
Pharmaceutical company Endo (OTCQX:NDOI) said that Blaise Coleman will depart the company as President & CEO and from the Board of Directors, effective on August 29, 2024. Scott Hirsch has been...
ENDO ANNOUNCES CEO TRANSITION - Yahoo Finance Canada
Endo, Inc. (OTCQX: NDOI) ("Endo" or the "Company"), a diversified specialty pharmaceutical company transforming insights into life-enhancing therapies, today announced that the Board of Directors...
Endo Names Blaise Coleman President and Chief Executive Officer
Endo International plc (NASDAQ: ENDP) today announced that Blaise Coleman, who has served as the Company's Executive Vice President and Chief Financial Officer since 2016, will succeed Paul...
Endo Announces CEO Transition - BioSpace
“I’d like to thank Blaise for his many contributions to Endo and wish him well in his future endeavors,” said Interim CEO Scott Hirsch. “In the near term, our priority will be continued focus on execution across our branded, sterile injectables and generics portfolios as we position the Company for long-term growth.
Endo Names Blaise Coleman President and Chief Executive Officer
DUBLIN, Feb. 19, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that Blaise Coleman, who has served as the Company's Executive Vice President and Chief Financial...
Endo CEO Coleman Is Out, Four Months After Steering Through …
Endo is a company reborn, and will appoint a new CEO to lead its fresh adventure after announcing the sudden departure of former chief Blaise Coleman.
Endo, Inc. Initiates CEO Transition and Strategic Search - MSN
MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has announced a significant leadership change as Blaise Coleman steps down from his roles as President, CEO, and Board member, effective August 29, 2024...
Blaise Coleman - President & CEO at Endo International - The Org
Blaise Coleman was appointed President and Chief Executive Officer and a member of the Board of Directors, effective March 2020. He previously served Executive Vice President and Chief Financial Officer since December 2016.
Endo Names Blaise Coleman President and Chief Executive Officer
Endo International plc announced that Blaise Coleman, who has served as the Company’s Executive Vice President and Chief Financial Officer since 2016, will succeed Paul Campanelli as President and Chief Executive Officer and will become a member of the Board of Directors effective March 6, 2020.
Malvern’s Endo Finds New CEO, a Former Widener College …
Endo International, the Dublin-based pharmaceutical company that has its U.S. headquarters in Malvern, has found its new CEO in Blaise Coleman. The Widener University graduate is currently the company’s executive vice president and chief financial officer, a role he has been in for the last four years, writes John George for the Philadelphia ...
Blaise A Coleman, Endo International PLC: Profile and Biography ...
Blaise A Coleman is Former President/CEO at Endo International PLC. See Blaise A Coleman's compensation, career history, education, & memberships.
Blaise Coleman | Duke's Fuqua School of Business
Blaise Coleman is Executive Vice President and Chief Financial Officer for Endo International plc, a leading global specialty pharmaceutical company. Blaise joined Endo in January 2015 as its Senior Vice President, Global Finance Operations.
Blaise Coleman Net Worth (2024) - wallmine
The estimated Net Worth of Blaise Coleman is at least $3.72 Million dollars as of 29 March 2022. Mr Coleman owns over 125,573 units of Endo International plc stock worth over $126,463 and over the last 8 years he sold ENDP stock worth over $0.
BRIEF—Endo names Blaise Coleman as president and CEO
Ireland-incorporated Endo International yesterday announced that Blaise Coleman, who has served as the company's executive vice president and chief financial officer since 2016, will succeed Paul Campanelli as president and chief executive and will become a member of the board of directors effective March 6, 2020.